A novel role for TNFAIP2: Its correlation with invasion and metastasis in nasopharyngeal carcinoma

Modern Pathology

Volumn 24, Issue 2, 2011, Pages 175-184

  Chen, Lih Chyang ^a   Chen, Chia Chun ^a   Liang, Ying ^a   Tsang, Ngan Ming ^b   Chang, Yu Sun ^a   Hsueh, Chuen ^b  

^a CHANG GUNG UNIVERSITY   (Taiwan)

^b CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

Author keywords

metastasis; migration; nasopharyngeal carcinoma; TNFAIP2

Indexed keywords

PROTEIN TNFAIP2; SMALL INTERFERING RNA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; CANCER INVASION; CELL MIGRATION; CONTROLLED STUDY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MAJOR CLINICAL STUDY; MALE; MICROENVIRONMENT; NASOPHARYNX CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR BIOPSY; TUMOR CELL; TUMOR GROWTH;

ADOLESCENT; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA; CELL LINE, TUMOR; CELL MOVEMENT; CELL PROLIFERATION; CYTOKINES; DISEASE PROGRESSION; DISEASE-FREE SURVIVAL; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NASOPHARYNGEAL NEOPLASMS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; NEOPLASM STAGING; PROGNOSIS; RETROSPECTIVE STUDIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TISSUE ARRAY ANALYSIS;

EID: 79551623537     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.2010.193     Document Type: Article

References (41)

1. Sethi G, Sung B, Aggarwal BB. TNF: a master switch for inflammation to cancer. Front Biosci 2008;13:5094-5107.
2. Balkwill F. TNF-alpha in promotion and progression of cancer. Cancer Metast Rev 2006;25:409-416.
3. Balkwill F. Tumour necrosis factor and cancer. Nat Rev Cancer 2009;9:361-371.
4. Pfitzenmaier J, Vessella R, Higano CS, et al. Elevation of cytokine levels in cachectic patients with prostate carcinoma. Cancer 2003;97:1211-1216.
5. Bozcuk H, Uslu G, Samur M, et al. Tumour necrosis factor-alpha, interleukin-6, and fasting serum insulin correlate with clinical outcome in metastatic breast cancer patients treated with chemotherapy. Cytokine 2004;27:58-65.
6. Hsiao SH, Lee MS, Lin HY, et al. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma. Acta Otolaryngol 2009;129:1519-1523.
7. Yadav M. Endogenous tumor necrosis factor-alpha in patients with nasopharyngeal carcinoma. Southeast Asian J Trop Med Public Health 1991;22:123-126.
8. Wei WI, Sham JS. Nasopharyngeal carcinoma. Lancet 2005;365:2041-2054.
9. Lee AW, Poon YF, Foo W, et al. Retrospective analysis of 5037 patients with nasopharyngeal carcinoma treated during 1976-1985: overall survival and patterns of failure. Int J Radiat Oncol Biol Phys 1992;23: 261-270.
10. Tse KP, Tsang NM, Chen KD, et al. MCP-1 promoter polymorphism at 2518 is associated with metastasis of nasopharyngeal carcinoma after treatment. Clin Cancer Res 2007;13:6320-6326.
11. Guigay J. Advances in nasopharyngeal carcinoma. Curr Opin Oncol 2008;20:264-269.
12. Ries C, Kolb H, Petrides PE. Regulation of 92-kD gelatinase release in HL-60 leukemia cells: tumor necrosis factor-alpha as an autocrine stimulus for basal- and phorbol ester-induced secretion. Blood 1994;83:3638-3646.
13. Kerkela E, Ala-aho R, Klemi P, et al. Metalloelastase (MMP-12) expression by tumour cells in squamous cell carcinoma of the vulva correlates with invasiveness, while that by macrophages predicts better outcome. J Pathol 2002;198:258-269.
14. Ray BK, Shakya A, Turk JR, et al. Induction of the MMP-14 gene in macrophages of the atherosclerotic plaque: role of SAF-1 in the induction process. Circ Res 2004;95:1082-1090.
15. Takada Y, Khuri FR, Aggarwal BB. Protein farnesyltransferase inhibitor (SCH 66336) abolishes NF-kappaB activation induced by various carcinogens and inflammatory stimuli leading to suppression of NFkappaB- regulated gene expression and up-regulation of apoptosis. J Biol Chem 2004;279:26287-26299.
16. Suto H, Katakai T, Sugai M, et al. CXCL13 production by an established lymph node stromal cell line via lymphotoxin-beta receptor engagement involves the cooperation of multiple signaling pathways. Int immunol 2009;21:467-476.
17. Kelleher P, Maroof A, Knight SC. Retrovirally induced switch from production of IL-12 to IL-4 in dendritic cells. Eur J Immunol 1999;29:2309-2318.
18. Spanaus KS, Schlapbach R, Fontana A. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligandinduced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL. Eur J Immunol 1998;28:4398-4408.
19. Chen LC, Hsueh C, Tsang NM, et al. Heterogeneous ribonucleoprotein k and thymidine phosphorylase are independent prognostic and therapeutic markers for nasopharyngeal carcinoma. Clin Cancer Res 2008;14:3807-3813.
20. Chen CC, Chen LC, Liang Y, et al. Epstein-Barr virus latent membrane protein 1 induces the chemotherapeutic target, thymidine phosphorylase, via NF-kappaB and p38 MAPK pathways. Cell Signal 2010;22: 1132-1142.
21. Zhu GH, Lenzi M, Schwartz EL. The Sp1 transcription factor contributes to the tumor necrosis factor-induced expression of the angiogenic factor thymidine phosphorylase in human colon carcinoma cells. Oncogene 2002;21:8477-8485.
22. Chen LC, Liu HP, Li HP, et al. Thymidine phosphorylase mRNA stability and protein levels are increased through ERK-mediated cytoplasmic accumulation of hnRNP K in nasopharyngeal carcinoma cells. Oncogene 2009;28:1904-1915.
23. Sarma V, Wolf FW, Marks RM, et al. Cloning of a novel tumor necrosis factor-alpha-inducible primary response gene that is differentially expressed in development and capillary tube-like formation in vitro. J Immunol 1992;148:3302-3312.
24. Wolf FW, Sarma V, Seldin M, et al. B94, a primary response gene inducible by tumor necrosis factoralpha, is expressed in developing hematopoietic tissues and the sperm acrosome. J Biol Chem 1994;269: 3633-3640.
25. Colotta F, Allavena P, Sica A, et al. Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability. Carcinogenesis 2009;30:1073-1081.
26. Wei S, Kitaura H, Zhou P, et al. IL-1 mediates TNFinduced osteoclastogenesis. J Clin Invest 2005;115: 282-290.
27. Gutierrez-Canas I, Juarranz Y, Santiago B, et al. VIP down-regulates TLR4 expression and TLR4-mediated chemokine production in human rheumatoid synovial fibroblasts. Rheumatology (Oxford) 2006;45:527-532.
28. Mukai Y, Wang CY, Rikitake Y, et al. Phosphatidylinositol 3-kinase/protein kinase Akt negatively regulates plasminogen activator inhibitor type 1 expression in vascular endothelial cells. Am J Physiol Heart Circ Physiol 2007;292:H1937-H1942.
29. Chen LC, Chung IC, Hsueh C, et al. The antiapoptotic protein, FLIP, is regulated by heterogeneous nuclear ribonucleoprotein K and correlates with poor overall survival of nasopharyngeal carcinoma patients. Cell Death Differ 2010;17:1463-1473.
30. Guang-Wu H, Sunagawa M, Jie-En L, et al. The relationship between microvessel density, the expression of vascular endothelial growth factor (VEGF), and the extension of nasopharyngeal carcinoma. Laryngoscope 2000;110:2066-2069.
31. Hsu SC, TerBush D, Abraham M, et al. The exocyst complex in polarized exocytosis. Int Rev Cytol 2004;233:243-265.
32. Tsuboi T, Ravier MA, Xie H, et al. Mammalian exocyst complex is required for the docking step of insulin vesicle exocytosis. J Biol Chem 2005;280: 25565-25570.
33. Frater-Schroder M, Risau W, Hallmann R, et al. Tumor necrosis factor type alpha, a potent inhibitor of endothelial cell growth in vitro, is angiogenic in vivo. Proc Natl Acad Sci USA 1987;84:5277-5281.
34. Leibovich SJ, Polverini PJ, Shepard HM, et al. Macrophage- induced angiogenesis is mediated by tumour necrosis factor-alpha. Nature 1987;329:630-632.
35. Ryuto M, Ono M, Izumi H, et al. Induction of vascular endothelial growth factor by tumor necrosis factor alpha in human glioma cells. Possible roles of SP-1. J Biol Chem 1996;271:28220-28228.
36. Yin Y, Wang S, Sun Y, et al. JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells. Biomed Pharmacother 2009;63:429-435.
37. Wang X, Lin Y. Tumor necrosis factor and cancer, buddies or foes? Acta Pharmacol Sin 2008;29:1275-1288.
38. Rusiniak ME, Yu M, Ross DT, et al. Identification of B94 (TNFAIP2) as a potential retinoic acid target gene in acute promyelocytic leukemia. Cancer Res 2000;60: 1824-1829.
39. Beckers J, Herrmann F, Rieger S, et al. Identification and validation of novel ERBB2 (HER2, NEU) targets including genes involved in angiogenesis. Int J Cancer 2005;114:590-597.
40. Rivera SP, Saarikoski ST, Sun W, et al. Identification of novel dioxin-responsive genes by representational difference analysis. Xenobiotica 2007;37:271-279.
41. Huang YT, Sheen TS, Chen CL, et al. Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells. Cancer Res 1999;59:1599-1605.